Discovery of Pyrazole-Based Positron Emission Tomography Agent that Maps Histone Deacetylase 6 (HDAC6) in the Nonhuman Primate Brain

Histone deacetylase 6 (HDAC6) is a crucial target for the development of pharmaceuticals used in the treatment of neurodegenerative disorders. Here, we identified <b>16a</b> as a candidate of positron emission tomography (PET) tracer for HDAC6 imaging from pyrazole derivatives, which showed strong HDAC6 affinity (<i>K</i><sub>d</sub> = 1.66 nM) and higher accumulation in the brain of wild-type mice than in HDAC6 knockout mice. Following radiolabeling with fluorine-18, PET with [<sup>18</sup>F]<b>16a</b> exhibited heterogeneous uptake of radioactivity, corresponding to the biological distribution of HDAC6 in the monkey brain. These radioactive distributions were homogeneously diminished by the preadministration of ACY-775, a potent inhibitor of HDAC6, suggesting that radioactive accumulation in PET images could reflect the specific binding of [<sup>18</sup>F]<b>16a</b> with HDAC6. Thus, [<sup>18</sup>F]<b>16a</b> is a promising PET tracer for HDAC6 imaging that motivates future clinical research.

Authors

Institutions

Publication Details

Journal
Journal of Medicinal Chemistry
Published
2025-10-21
DOI
https://doi.org/10.1021/acs.jmedchem.5c02216
Citations
1
Primary Topic
Histone Deacetylase Inhibitors Research
Type
article
Field-Weighted Citation Impact
0.81
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Discovery of Pyrazole-Based Positron Emission Tomography Agent that Maps Histone Deacetylase 6 (HDAC6) in the Nonhuman Primate Brain

Tomoteru Yamasaki, Paul McQuade, Makoto Higuchi, Ignacio Ibáñez et al.
1 citations
Journal of Medicinal Chemistry
Histone Deacetylase Inhibitors Research
0.81
article

Discovery of Pyrazole-Based Positron Emission Tomography Agent that Maps Histone Deacetylase 6 (HDAC6) in the Nonhuman Primate Brain

Tomoteru Yamasaki, Paul McQuade, Makoto Higuchi, Ignacio Ibáñez, Naoki Inui, Takamitsu Maru, Satoshi Yamamoto, Taku Sugita, Ming‐Rong Zhang, Norio Ohyabu, Tomohiro Onishi, Takafumi Minamimoto, Wakana Mori, Sho Sato, Chie Seki, Makoto Fushimi, Akihiro Takano, Masayuki Fujinaga, Yuji Nagai, Kazunori Iwanaga, Yohei Kosugi, Takeshi Wakabayashi, Michiko Terada, Masahiko Hattori, Shoko Uchida
article en
1 citations

Abstract

Histone deacetylase 6 (HDAC6) is a crucial target for the development of pharmaceuticals used in the treatment of neurodegenerative disorders. Here, we identified <b>16a</b> as a candidate of positron emission tomography (PET) tracer for HDAC6 imaging from pyrazole derivatives, which showed strong HDAC6 affinity (<i>K</i><sub>d</sub> = 1.66 nM) and higher accumulation in the brain of wild-type mice than in HDAC6 knockout mice. Following radiolabeling with fluorine-18, PET with [<sup>18</sup>F]<b>16a</b> exhibited heterogeneous uptake of radioactivity, corresponding to the biological distribution of HDAC6 in the monkey brain. These radioactive distributions were homogeneously diminished by the preadministration of ACY-775, a potent inhibitor of HDAC6, suggesting that radioactive accumulation in PET images could reflect the specific binding of [<sup>18</sup>F]<b>16a</b> with HDAC6. Thus, [<sup>18</sup>F]<b>16a</b> is a promising PET tracer for HDAC6 imaging that motivates future clinical research.

Journal of Medicinal ChemistryVol. 68(21)
National Institutes for Quantum Science and Technology (JP), Takeda (United States) (US), Takeda (Japan) (JP)
Openalex Percentile: Top 22%
Histone Deacetylase Inhibitors Research
0.81
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.